13. Before we decide if we should conduct a detailed investigation of a complaint, we look at whether there are signs the organisation has got something wrong. We do this by comparing what should have happened with what did happen. We have done this and have not found any indications that something went wrong in the decision the Trust reached, or the care Mrs F received.
14. The NICE guideline on the care of dying adults in the last days of life sets out recommendations to support doctors to make a clinical judgement that an individual is reaching the end of their life. It explains there are changes in signs and symptoms that suggest an adult is in the last few days of their life. These changes can include agitation, a deterioration in level of consciousness, fatigue, and shallow breathing.
15. The guideline says doctors should consider treating a dying person who is experiencing ‘agitation’ and ‘anxiety’ with a benzodiazepine. This type of medicine slows down activity of vital organs and gives a person feelings of drowsiness, relaxation, and pain relief.
16. In the ED, Mrs F was treated with intravenous fluids, antibiotics, and steroids. Intravenous means the medicine and fluids was delivered directly into her vein. The Trust also treated Mrs F with oxygen. The records show Mrs F sadly did not respond to this treatment.
17. Mrs F was transferred to the AMU and was seen by a doctor just before 10pm. The doctor noted Mrs F’s breathing was shallow. He assessed her level of consciousness using the Glasgow Coma Scale. This assesses an individual’s ability to open their eyes, move, and speak. The doctor concluded that Mrs F was ‘unresponsive’ and was, sadly, dying.
18. The records show the doctor’s plan was for active treatment to stop and Mrs F to be given end of life care.
19. Our adviser said the doctor assessed Mrs F and made this decision in line with the NICE guideline. They said it was clear from the records that the doctor had seen the changes in signs and symptoms set out in the NICE guideline.
20. The records show on 19 October a doctor explained to Mrs F’s family that she had severe sepsis (a life-threatening reaction an infection), and her lungs, heart, and kidneys were not working as they should.
21. Mrs F was treated with morphine for pain relief and midazolam. Our adviser explained midazolam is a type of benzodiazepine. They said the Trust acted in line with the NICE guideline by treating Mrs F with these drugs.
22. Mr D was particularly concerned that Mrs F should not have been treated with midazolam because she had respiratory disease. Our adviser said the use of midazolam is not contraindicated (likely to be harmful) for people at the end of their life. This is set out in the NICE guideline. Our adviser explained all medication that is used to relieve distress and agitation at the end of life has the potential to cause slower breathing. They said this medication was important to ensure Mrs F was as comfortable as possible as she reached the end of her life.
23. We understand Mr D’s experience has caused him and Mrs F’s family distress and we do not underestimate how much of a difficult time this has been for all of them. We hope this statement reassures Mr D we have considered his complaint carefully and clearly explains our decision not to consider the issues further.